Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease - Takeaways - MDSpire

Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease

  • By

  • Li Jun Wang

  • Ping Zhang

  • Gui Li Wang

  • Shu Cheng Chen

  • Wei You Cao

  • Ji Chun Han

  • Jian Guang Sun

  • Jian Chao Feng

  • Yang Zheng

  • May 13, 2026

  • 0 min

Share

  • 1

    Schisandra chinensis Fructus (SCF) is a traditional herbal remedy known for its therapeutic properties in managing liver disorders.

  • 2

    SCF extract exhibits pharmacological effects such as hepatocyte protection, improved insulin sensitivity, and reduced oxidative stress.

  • 3

    The active metabolites of SCF, including lignans and triterpenoids, play a crucial role in alleviating metabolic dysfunction-associated steatotic liver disease (MASLD).

  • 4

    MASLD is a prevalent condition linked to obesity and metabolic syndrome, with a rising incidence expected to challenge public health.

  • 5

    Further research into the mechanisms of SCF's active compounds is essential for developing effective treatments and health products.

Original Source(s)

Schisandra chinensis Fructus and its active metabolites for the treatment of metabolic dysfunction-associated steatotic liver disease

  • by Li Jun Wang, Ping Zhang, Gui Li Wang, Shu Cheng Chen, Wei You Cao, Ji Chun Han, Jian Guang Sun, Jian Chao Feng, Yang Zheng

  • May 13, 2026

Related Content

The role of mitochondrial dynamics in metabolic dysfunction–associated steatotic liver disease

Meet Saro Khemichian, MD

Saro Khemichian, MD, is a transplant hepatologist with the USC Transplant Institute, part of Keck Medicine of USC, who cares for patients across the full spectrum of liver diseases, from mild liver conditions to advanced cirrhosis and liver failure, including those who have undergone a liver transplant.

  • by

  • April 27, 2026

  • 6 min
Covert hepatic encephalopathy as a multi-organ syndrome: the gut–liver–muscle–brain axis, diagnosis, treatment, and multidisciplinary care